AMRI Announces Third Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- S&P 500 ends marginally lower as investors focus on US-Iran war
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Plug Power COO resigns to join another company
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
Albany Molecular Research (AMRI) Tops Q3 EPS by 4c
November 8, 2016 7:44 AM ESTAlbany Molecular Research (NASDAQ: AMRI) reported Q3 EPS of $0.17, $0.04 better than the analyst estimate of $0.13. Revenue for the quarter came in at $151.7 million versus the consensus estimate of $160.75 million.
For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.
... More